Form 8-K - Current report:
SEC Accession No. 0000950170-24-056248
Filing Date
2024-05-09
Accepted
2024-05-09 07:02:22
Documents
60
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20240509.htm   iXBRL 8-K 42318
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 127378
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 49118
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 212696
6 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 723756
7 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 530401
8 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 536828
9 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 446072
10 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 421362
11 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 369165
12 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 394298
13 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 392779
14 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 377873
15 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 373279
16 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 372310
17 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 375147
18 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 451646
19 GRAPHIC lrmr-ex99_2s15.jpg GRAPHIC 417879
20 GRAPHIC lrmr-ex99_2s16.jpg GRAPHIC 524727
21 GRAPHIC lrmr-ex99_2s17.jpg GRAPHIC 198904
22 GRAPHIC lrmr-ex99_2s18.jpg GRAPHIC 370273
23 GRAPHIC lrmr-ex99_2s19.jpg GRAPHIC 380762
24 GRAPHIC lrmr-ex99_2s20.jpg GRAPHIC 361983
25 GRAPHIC lrmr-ex99_2s21.jpg GRAPHIC 392386
26 GRAPHIC lrmr-ex99_2s22.jpg GRAPHIC 372344
27 GRAPHIC lrmr-ex99_2s23.jpg GRAPHIC 537086
28 GRAPHIC lrmr-ex99_2s24.jpg GRAPHIC 213065
29 GRAPHIC lrmr-ex99_2s25.jpg GRAPHIC 201536
30 GRAPHIC lrmr-ex99_2s26.jpg GRAPHIC 389858
31 GRAPHIC lrmr-ex99_2s27.jpg GRAPHIC 291119
32 GRAPHIC lrmr-ex99_2s28.jpg GRAPHIC 158601
33 GRAPHIC lrmr-ex99_2s29.jpg GRAPHIC 446207
34 GRAPHIC lrmr-ex99_2s30.jpg GRAPHIC 346007
35 GRAPHIC lrmr-ex99_2s31.jpg GRAPHIC 310056
36 GRAPHIC lrmr-ex99_2s32.jpg GRAPHIC 437712
37 GRAPHIC lrmr-ex99_2s33.jpg GRAPHIC 377660
38 GRAPHIC lrmr-ex99_2s34.jpg GRAPHIC 354108
39 GRAPHIC lrmr-ex99_2s35.jpg GRAPHIC 141917
40 GRAPHIC lrmr-ex99_2s36.jpg GRAPHIC 390505
41 GRAPHIC lrmr-ex99_2s37.jpg GRAPHIC 438185
42 GRAPHIC lrmr-ex99_2s38.jpg GRAPHIC 345529
43 GRAPHIC lrmr-ex99_2s39.jpg GRAPHIC 349993
44 GRAPHIC lrmr-ex99_2s40.jpg GRAPHIC 355152
45 GRAPHIC lrmr-ex99_2s41.jpg GRAPHIC 241721
46 GRAPHIC lrmr-ex99_2s42.jpg GRAPHIC 163532
47 GRAPHIC lrmr-ex99_2s43.jpg GRAPHIC 289792
48 GRAPHIC lrmr-ex99_2s44.jpg GRAPHIC 347991
49 GRAPHIC lrmr-ex99_2s45.jpg GRAPHIC 148487
50 GRAPHIC lrmr-ex99_2s46.jpg GRAPHIC 420311
  Complete submission text file 0000950170-24-056248.txt   23710176

Data Files

Seq Description Document Type Size
51 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20240509.xsd EX-101.SCH 23892
63 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20240509_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 24928480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)